text:
Chapter 12 : Chemokines and the Neuropathogenesis of HIV-1 Infection
Authors: Dawn Eggert1, Eric Anderson2, Jialin Zheng3, Howard E. Gendelman4
Affiliations: 1: Laboratory of Neuroregeneration, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68398-5880; 2: Laboratory of Neuroregeneration, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68398-5880; 3: Laboratory of Neurotoxicology, Department of Pharmacology and Experimental Neuroscience, Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68398-5880; 4: Laboratory of Neuroregeneration, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68398-5880
Chemokines and the Neuropathogenesis of HIV-1 Infection, Page 1 of 2
Human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorder (HAND) is commonly associated with a multinucleated giant cell (MNGC) encephalitis termed HIV encephalitis (HIVE). Importantly, it occurs in most, but not all, cases of dementia related to HIV-1 infection. This chapter strives to describe what is known about multinuclear phagocytes (MP) activation and neuronal dysfunction with a focus on chemokines. Mounting evidence suggests that chemokines affect the pathogenesis of HAND. First, there is a state of "immune privilege" within the central nervous system (CNS) that is, in part, an evolutionary adaptation for which increasing evidence suggests that functional immunity is quite operative in the brain. Second, the maintenance of nervous system function requires protection from a variety of environmental insults occurring during inflammatory activities, such as HIVE. Third, chemokines (chemotactic cytokines) and chemokine receptors are an important part of the immune response that affects cell migration, activation, and tissue homeostasis. Fourth, following local production, chemokines induce leukocyte cytoskeletal changes, for example, actin polymerization, optimizing cell migration to areas of microbial infection or degeneration. Chemokine receptors are critical for the infection of perivascular macrophages and microglia. It has also been shown that chemokines and their receptors play a more direct role in the neuropathogenesis of HIV-1 infection. The neuropathogenesis of HIV-1 infection revolves around inflammatory factors secreted from virus-infected and immunocompetent brain MP. Chemokines and their chemokine receptors are expressed in the nervous system, and their engagement affects neuronal and glial function.
Citation: Eggert D, Anderson E, Zheng J, Gendelman H. 2009. Chemokines and the Neuropathogenesis of HIV-1 Infection, p 151-171. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch12
Chemokines and the Neuropathogenesis of HIV-1 Infection
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815691.ch12-1,webId=/content/author/10.1128/9781555815691.ch12-1,properties={foaf_givenname=Dawn, foaf_name=Dawn Eggert, foaf_surname=Eggert, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815691.ch12-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815691.ch12-2,webId=/content/author/10.1128/9781555815691.ch12-2,properties={foaf_givenname=Eric, foaf_name=Eric Anderson, foaf_surname=Anderson, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815691.ch12-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815691.ch12-3,webId=/content/author/10.1128/9781555815691.ch12-3,properties={foaf_givenname=Jialin, foaf_name=Jialin Zheng, foaf_surname=Zheng, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815691.ch12-aff3]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815691.ch12-4,webId=/content/author/10.1128/9781555815691.ch12-4,properties={foaf_givenname=Howard E., foaf_name=Howard E. Gendelman, foaf_surname=Gendelman, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815691.ch12-aff4]]}]]
A proposed pathophysiological mechanism for how chemokines and their receptors influence the neuropathogenesis of HIV-1 infection. Transendothelial migration of monocytes into the nervous system is affected by chemokines produced by activated microglia and astrocytes. Productive HIV-1 infection is sustained in infected macrophages, although the process by which these macrophages become immunoactivated remains incompletely understood. Macrophages secrete a variety of factors, including cytokines and α and β chemokines, which affect CNS inflammation and neuronal function. Neural compromise is a consequence of intracellular signal transduction alterations induced by chemokines, HIV-1 gp120, Tat, and whole virions. Neural survival and apoptosis may be induced by chemokines.
1. Achim, C. L.,, R. Wang,, D. K. Miners, and, C. A. Wiley. 1994. Brain viral burden in HIV infection. J. Neuropathol. Exp. Neurol. 53: 284– 294.
2. Adamson, D. C.,, B. Wildemann,, M. Sasaki,, J. D. Glass,, J. C. McArthur,, V. I. Christov,, T. M. Dawson, and, V. L. Dawson. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917– 1926.
3. Albright, A. V.,, J. T. Shieh,, T. Itoh,, B. Lee,, D. Pleasure,, M. J. O'Connor,, R. W. Doms, and, F. Gonzalez-Scarano. 1999. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 73: 205– 213.
4. Albright, A. V.,, S. A. Soldan, and, F. Gonzalez-Scarano. 2003. Pathogenesis of human immunodeficiency virus-induced neurological disease. J. Neurovirol. 9: 222– 227.
6. Ancuta, P.,, A. Moses, and, D. Gabuzda. 2004. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 209: 11– 20.
7. Anderson, E.,, W. Zink,, H. Xiong, and, H. E. Gendelman. 2002. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 31 (Suppl. 2) : S43– S54.
8. Annunziata, P. 2003. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J. Neurol. 250: 901– 906.
9. Antinori, A.,, G. Arendt,, J. T. Becker,, B. J. Brew,, D. A. Byrd,, M. Cherner,, D. B. Clifford,, P. Cinque,, L. G. Epstein,, K. Goodkin,, M. Gisslen,, I. Grant,, R. K. Heaton,, J. Joseph,, K. Marder,, C. M. Marra,, J. C. McArthur,, M. Nunn,, R. W. Price,, L. Pulliam,, K. R. Robertson,, N. Sacktor,, V. Valcour, and, V. E. Wojna. 2007. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789– 1799.
10. Aquaro, S.,, E. Balestra,, A. Cenci,, M. Francesconi,, R. Calio, and, C. F. Perno. 1997. HIV infection in macrophage: role of long-lived cells and related therapeutical strategies. J. Biol. Regul. Homeost. Agents 11: 69– 73.
11. Aquaro, S.,, R. Calio,, E. Balestra,, P. Bagnarelli,, A. Cenci,, A. Bertoli,, B. Tavazzi,, D. Di Pierro,, M. Francesconi,, D. Abdelahad, and, C. F. Perno. 1998. Clinical implications of HIV dynamics and drug resistance in macrophages. J. Biol. Regul. Homeost. Agents 12: 23– 27.
12. Aquaro, S.,, S. Panti,, M. C. Caroleo,, E. Balestra,, A. Cenci,, F. Forbici,, G. Ippolito,, A. Mastino,, R. Testi,, V. Mollace,, R. Calio, and, C. F. Perno. 2000. Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes. J. Leukoc. Biol. 68: 429– 435.
13. Arenzana-Seisdedos, F.,, and M. Partmentier. 2006. Genetics of resistance to HIV infection: role of co-receptors and co-receptor ligands. Semin. Immunol. 18: 387– 403.
14. Babcock, A. A.,, W. A. Kuziel,, S. Rivest, and, T. Owens. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23: 7922– 7930.
15. Baggiolini, M.,, B. Dewald, and, B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675– 705.
16. Bajetto, A.,, R. Bonavia,, S. Barbero, and, G. Schettini. 2002. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82: 1311– 1329.
17. Banisadr, G.,, E. Dicou,, T. Berbar,, W. Rostene,, A. Lombet, and, F. Haour. 2000. Characterization and visualization of (125I) stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J. Neuroimmunol. 110: 151– 160.
18. Batchelor, P. E.,, G. T. Liberatore,, J. Y. Wong,, M. J. Porritt,, F. Frerichs,, G. A. Donnan, and, D. W. Howells. 1999. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19: 1708– 1716.
19. Bazan, H. A.,, G. Alkhatib,, C. C. Broder, and, E. A. Berger. 1998. Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates. J. Virol. 72: 4485– 4491.
20. Bazan, J.,, K. Bacon,, G. Hardiman,, W. Wang,, K. Soo,, D. Rossi,, D. Greaves,, A. Zlotnik, and, T. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640– 644.
21. Berger, J. R.,, and E. O. Major. 1999. Progressive multifocal leukoencephalopathy. Semin. Neurol. 19: 193– 200.
22. Bernasconi, S.,, P. Cinque,, G. Peri,, S. Sozzani,, A. Crociati,, W. Torri,, E. Vicenzi,, L. Vago,, A. Lazzarin,, G. Poli, and, A. Mantovani. 1996. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J. Infect. Dis. 174: 1098– 1101.
23. Bezzi, P.,, M. Domercq,, L. Brambilla,, R. Galli,, D. Schols,, E. De Clercq,, A. Vescovi,, G. Bagetta,, G. Kollias,, J. Meldolesi, and, A. Volterra. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4: 702– 710.
24. Bleul, C. C.,, M. Farzan,, H. Choe,, C. Parolin,, I. Clark-Lewis,, J. Sodroski, and, T. A. Springer. 1996a. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829– 833.
25. Bleul, C. C.,, R. C. Fuhlbrigge,, J. M. Casasnovas,, A. Aiuti, and, T. A. Springer. 1996b. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184: 1101– 1109.
26. Boehme, S. A.,, F. M. Lio,, D. Maciejewski-Lenoir,, K. B. Bacon, and, P. J. Conlon. 2000. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165: 397– 403.
27. Boutet, A.,, H. Salim,, P. Leclerc, and, M. Tardieu. 2001. Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons. Neurosci. Lett. 311: 105– 108.
28. Boven, L. A.,, J. Middel,, E. C. Breij,, D. Schotte,, J. Verhoef,, C. Soderland, and, H. S. Nottet. 2000. Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines. J. Neurovirol. 6: 382– 389.
29. Brack-Werner, R. 1999. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13: 1– 22.
30. Brandimarti, R.,, M. Z. Khan,, A. Fatatis, and, O. Meucci. 2004. Regulation of cell cycle proteins by chemokine receptors: a novel pathway in human immunodeficiency virus neuropathogenesis? J. Neurovirol. 10 (Suppl. 1) : 108– 112.
31. Brenneman, D. E.,, G. L. Westbrook,, S. P. Fitzgerald,, D. L. Ennist,, K. L. Elkins,, M. R. Ruff, and, C. B. Pert. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639– 642.
32. Brew, B.,, R. Bhalla,, M. Paul,, H. Gallardo,, J. C. McArthur,, M. K. Schwartz, and, R. W. Price. 1990. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann. Neurol. 28: 556– 560.
33. Brew, B. J.,, L. Evans,, C. Byrne,, L. Pemberton, and, L. Hurren. 1996a. The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. J. Neurovirol. 2: 152– 157.
34. Brew, B. J.,, and J. Miller. 1996. Human immunodeficiency virus type 1-related transient neurological deficits. Am. J. Med. 101: 257– 261.
35. Brew, B. J.,, S. L. Wesselingh,, M. Gonzales,, M. P. Heyes, and, R. W. Price. 1996b. How HIV leads to neurological disease. Med. J. Aust. 164: 233– 234.
36. Broder, C. C.,, and R. G. Collman. 1997. Chemokine receptors and HIV. J. Leukoc. Biol. 62: 20– 29.
37. Caroleo, M. C.,, N. Costa,, L. Bracci-Laudiero, and, L. Aloe. 2001. Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. J. Neuroimmunol. 113: 193– 201.
38. Carpenter, C. C.,, D. A. Cooper,, M. A. Fischl,, J. M. Gatell,, B. G. Gazzard,, S. M. Hammer,, M. S. Hirsch,, D. M. Jacobsen,, D. A. Katzenstein,, J. S. Montaner,, D. D. Richman,, M. S. Saag,, M. Schechter,, R. T. Schooley,, M. A. Thompson,, S. Vella,, P. G. Yeni, and, P. A. Volberding. 2000. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283: 381– 390.
39. Cartier, L.,, O. Hartley,, M. Dubois-Dauphin, and, K. H. Krause. 2005. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48: 16– 42.
40. Chakrabarti, L.,, M. Hurtrel,, M. A. Maire,, R. Vazeux,, D. Dormont,, L. Montagnier, and, B. Hurtrel. 1991. Early viral replication in the brain of SIV-infected rhesus monkeys. Am. J. Pathol. 139: 1273– 1280.
41. Chang, J.,, R. Jozwiak,, B. Wang,, T. Ng,, Y. C. Ge,, W. Bolton,, D. E. Dwyer,, C. Handle,, R. Osborn,, A. C. Cunningham, and, N. D. Saksena. 1998. Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. AIDS Res. Hum. Retrovir. 14: 25– 30.
42. Chapman, G. A.,, K. Moores,, D. Harrison,, C. A. Campbell,, B. R. Stewart, and, P. J. Trijbos. 2000a. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20: RC87.
43. Chapman, G. A.,, K. E. Moores,, J. Gohil,, T. A. Berkhout,, L. Patel,, P. Green,, C. H. Macphee, and, B. R. Stewart. 2000b. The role of fractalkine in the recruitment of monocytes to the endothelium. Eur. J. Pharmacol. 392: 189– 195.
44. Chauhan, A.,, and A. Nath. 2005. Mechanisms of neuronal demise in HIV dementia: role of HIV-1 Tat, p. 193–199. In H. E. Gendelman,, I. Grant,, I. P. Everall,, S. A. Lipton, and, S. Swindells (ed.), The Neurology of AIDS, 2nd ed. Oxford University Press, New York, NY.
45. Chauhan, A.,, J. Turchan,, C. Pocernich,, A. Bruce-Keller,, S. Roth,, D. A. Butterfield,, E. O. Major, and, A. Nath. 2003. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278: 13512– 13519.
46. Chen, S.,, D. L. Tuttle,, J. T. Oshier,, H. J. Knot,, W. J. Streit,, M. M. Goodenow, and, J. K. Harrison. 2005. Transforming growth factor-beta 1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology 114: 565– 574.
47. Chew, C. B.,, S. J. Potter,, B. Wang,, Y. M. Wang,, C. O. Shaw,, D. E. Dwyer, and, N. K. Saksena. 2005. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J. Clin. Virol. 33: 206– 216.
48. Cho, C.,, and R. J. Miller. 2002. Chemokine receptors and neural function. J. Neurovirol. 8: 573– 584.
49. Choe, H.,, M. Farzan,, M. Konkel,, K. Martin,, Y. Sun,, L. Marcon,, M. Cayabyab,, M. Berman,, M. E. Dorf,, N. Gerard,, C. Gerard, and, J. Sodroski. 1998a. The orphan seven-trans-membrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J. Virol. 72: 6113– 6118.
50. Choe, H.,, K. A. Martin,, M. Farzan,, J. Sodroski,, N. P. Gerard, and, C. Gerard. 1998b. Structural interactions between chemokine receptors, gp120 Env and CD4. Semin. Immunol. 10: 249– 257.
51. Chung, I.,, M. Zelivyanskaya, and, H. E. Gendelman. 2002. Mononuclear phagocyte biophysiology influences brain transendothelial and tissue migration: implication for HIV-1-associated dementia. J. Neuroimmunol. 122: 40– 54.
52. Cinque, P.,, L. Vago,, M. Mengozzi,, V. Torri,, D. Ceresa,, E. Vicenzi,, P. Transidico,, A. Vagani,, S. Sozzani,, A. Mantovani,, A. Lazzarinand, and, G. Poli. 1998. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12: 1327– 1332.
53. Cocchi, F.,, A. L. DeVico,, A. Garzino-Demo,, S. K. Arya,, R. C. Gallo, and, P. Lusso. 1995. Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811– 1815.
54. Coleman, P.,, and D. Flood. 1987. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 8: 521– 545.
55. Conant, K.,, A. Garzino-Demo,, A. Nath,, J. C. McArthur,, W. Halliday,, C. Power,, R. C. Gallo, and, E. O. Major. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95: 3117– 3121.
56. Conti, L.,, L. Fantuzzi,, M. Del Corno,, F. Belardelli, and, S. Gessani. 2004. Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: implications for AIDS pathogenesis. Immunobiology 209: 99– 115.
57. Cook-Easterwood, J.,, L. D. Middaugh,, W. C. Griffen, 3rd,, I. Khan, and, W. R. Tyor. 2007. Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp. Neurol. 205: 506– 512.
58. Cotter, R.,, C. Williams,, L. Ryan,, D. Erichsen,, A. Lopez,, H. Peng, and, J. Zheng. 2002. Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 8: 585– 598.
59. Cotter, R.,, J. Zheng,, M. Che,, D. Niemann,, Y. Liu,, J. He,, E. Thomas, and, H. E. Gendelman. 2001. Regulation of HIV-1 infection, b-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry. J. Virol. 75: 4308– 4320.
60. Cotter, R. L.,, W. J. Burke,, V. S. Thomas,, J. F. Potter,, J. Zheng, and, H. E. Gendelman. 1999. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J. Leukoc. Biol. 65: 416– 427.
61. Coughlan, C. M.,, C. M. McManus,, M. Sharron,, Z. Gao,, D. Murphy,, S. Jaffer,, W. Choe,, W. Chen,, J. Hesselgesser,, H. Gaylord,, A. Kalyuzhny,, V. M. Lee,, B. Wolf,, R. W. Doms, and, D. L. Kolson. 2000. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97: 591– 600.
62. Croitoru-Lamoury, J.,, G. J. Guillemin,, F. D. Boussin,, B. Mognetti,, L. I. Gigout,, A. Cheret,, B. Vaslin,, R. Le Grand,, B. J. Brew, and, D. Dormont. 2003. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41: 354– 370.
63. Dallasta, L. M.,, L. A. Pisarov,, J. E. Esplen,, J. V. Werley,, A. V. Moses,, J. A. Nelson, and, C. L. Achim. 1999. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155: 1915– 1927.
64. Davis, C. B.,, I. Dikic,, D. Unutmaz,, C. M. Hill,, J. Arthos,, M. A. Siani,, D. A. Thompson,, J. Schlessinger, and, D. R. Littman. 1997. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186: 1793– 1798.
65. Davis, L. E.,, B. L. Hjelle,, V. E. Miller,, D. L. Palmer,, A. L. Llewellyn,, T. L. Merlin,, S. A. Young,, R. G. Mills,, W. Wachsman, and, C. A. Wiley. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736– 1739.
66. Deng, H.,, R. Liu,, W. Ellmeier,, S. Choe,, D. Unutmaz,, M. Burkhart,, P. Di Marzio,, S. Marmon,, R. E. Sutton,, C. M. Hill,, C. B. Davis,, S. C. Peiper,, T. J. Schall,, D. R. Littman, and, N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661– 666.
67. Desbaillets, I.,, M. Tada,, N. de Tribolet,, A. C. Diserens,, M. F. Hamou, and, E. G. Van Meir. 1994. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer 58: 240– 247.
68. Di Stefano, M.,, S. Wilt,, F. Gray,, M. Dubois-Dalcq, and, F. Chiodi. 1996. HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res. Hum. Retrovir. 12: 471– 482.
69. Dong, X. N.,, Y. Wu,, J. Ying, and, Y. H. Chen. 2005. The antigenic tip GPGRAFY of the V3 loop on HIV-1 gp120: genetic variability and subtypes. Immunol. Lett. 101: 112– 114.
70. Dooms, H.,, T. Van Belle,, M. Desmedt,, P. Rottiers, and, J. Grooten. 2000. Interleukin-15 redirects the outcome of a tolerizing T-cell stimulus from apoptosis to anergy. Blood 96: 1006– 1012.
71. Doranz, B. J.,, J. Rucker,, Y. Yi,, R. J. Smyth,, M. Samson,, S. C. Peiper,, M. Parmentier,, R. G. Collman, and, R. W. Dome. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β chemokine receptor CKR5, CKR3, and CKR-2b as fusion cofactors. Cell 85: 1149– 1158.
72. Dorf, M. E.,, M. A. Berman,, S. Tanabe,, M. Heesen, and, Y. Luo. 2000. Astrocytes express functional chemokine receptors. J. Neuroimmunol. 111: 109– 121.
73. Dragic, T.,, V. Litwin,, G. P. Allaway,, S. R. Martin,, Y. Huang,, K. A. Nagashima,, C. Cayanan,, P. J. Maddon,, R. A. Koup,, J. P. Moore, and, W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokines receptor CC-CKR-5. Nature 381: 667– 673.
74. Dunfee, R.,, E. R. Thomas,, P. R. Gorry,, J. Wang,, P. Ancuta, and, D. Gabuzda. 2006. Mechanisms of HIV-1 neurotropism. Curr. HIV Res. 4: 267– 278.
75. Dzenko, K. A.,, L. Song,, S. Ge,, W. A. Kuziel, and, J. S. Pachter. 2005. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2. Microvasc. Res. 70: 53– 64.
76. Edinger, A. L.,, C. Blanpain,, K. J. Kunstman,, S. M. Wolinsky,, M. Parmentier, and, R. W. Doms. 1999. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J. Virol. 73: 4062– 4073.
77. El-Hage, N.,, J. A. Gurwell,, I. N. Singh,, P. E. Knapp,, A. Nath, and, K. F. Hauser. 2005. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50: 91– 106.
78. Elkabes, S.,, E. M. DiCicco-Bloom, and, I. B. Black. 1996. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16: 2508– 2521.
79. Endres, M. J.,, P. R. Clapham,, M. Marsh,, M. Ahuja,, J. D. Turner,, A. McKnight,, J. F. Thomas,, B. Stoebenau-Haggarty,, S. Choe,, P. J. Vance,, T. N. C. Wells,, C. A. Powers,, S. S. Sutterwala,, R. W. Doms,, N. R. Landau, and, J. A. Hoxie. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87: 745– 756.
80. Erdmann, N. B.,, N. P. Whitney, and, J. Zheng. 2006. Potentiation of excitotoxicity in HIV-1 associated dementia and the significance of glutaminase. Clin. Neurosci. Rex. 6: 315– 328.
81. Erichsen, D.,, A. L. Lopez,, H. Peng,, D. Niemann,, C. Williams,, M. Bauer,, S. Morgello,, R. L. Cotter,, L. A. Ryan,, A. Ghorpade,, H. E. Gendelman, and, J. Zheng. 2003. Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J. Neuroimmunol. 138: 144-155.
82. Eugenin, E. A.,, and J. W. Berman. 2007. Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J. Neurosci. 27: 12844– 12850.
83. Everall, I. P.,, J. D. Glass,, J. McArthur,, E. Spargo, and, P. Lantos. 1994. Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol. 88: 538– 544.
84. Fallon, J.,, S. Reid,, R. Kinyamu,, I. Opole,, R. Opole,, J. Baratta,, M. Korc,, T. L. Endo,, A. Duong,, G. Nguyen,, M. Karkehabadhi,, D. Twardzik,, S. Patel, and, S. Loughlin. 2000. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc. Natl. Acad. Sci. USA 97: 14686– 14691.
85. Farzan, M.,, H. Choe,, K. Martin,, L. Marcon,, W. Hofmann,, G. Karlsson,, Y. Sun,, P. Barrett,, N. Marchand,, N. Sullivan,, N. Gerard,, C. Gerard, and, J. Sodroski. 1997a. Two orphan seven transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186: 405– 411.
86. Farzan, M.,, H. Choe,, K. A. Martin,, Y. Sun,, M. Sidelko,, C. R. Mackay,, N. P. Gerard,, J. Sodroski, and, C. Gerard. 1997b. HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272: 6854– 6857.
87. Feng, Y.,, C. C. Broder,, P. E. Kennedy, and, E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872– 877.
88. Fiala, M.,, X. H. Gan,, L. Zhang,, S. D. House,, T. Newton,, M. C. Graves,, P. Shapshak,, M. Stins,, K. S. Kim,, M. Witte, and, S. L. Chang. 1998. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis. Adv. Exp. Med. Biol. 437: 199– 205.
89. Fischer-Smith, T.,, S. Croul,, A. Adeniyi,, K. Rybicka,, S. Morgello,, K. Khalili, and, J. Rappaport. 2004. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am. J. Pathol. 164: 2089– 2099.
91. Fischer-Smith, T.,, E. M. Tedaldi, and, J. Rappaport. 2008. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res. Hum. Retrovir. 24: 417– 421.
92. Flynn, G.,, S. Maru,, J. Loughlin,, I. A. Romero, and, D. Male. 2003. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136: 84– 93.
93. Fox, H. S.,, M. R. Weed,, S. Huitron-Resendiz,, J. Baig,, T. F. Horn,, P. J. Dailey,, N. Bischofberger, and, S. J. Henriksen. 2000. Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J. Clin. Investig. 106: 37– 45.
94. Gabuzda, D.,, J. He,, A. Ohagen, and, A. Vallat. 1998. Chemokine receptors in HIV-1 infection of the central nervous system. Immunology 10: 203– 213.
95. Gabuzda, D.,, and J. Wang. 1999. Chemokine receptors and virus entry in the central nervous system. J. Neurovirol. 5: 643– 658.
96. Gabuzda, D.,, J. Wang, and, P. Gorry. 2002. HIV-1-associated dementia, p. 345–360. In R. M. Ransohoff,, K. Suzuki,, A. E. I. Proudfoot,, W. F. Hickey, and, J. K. Harrison (ed.), Chemokines and the Nervous System. Elsevier Science, Amsterdam, The Netherlands.
97. Gabuzda, D. H.,, D. D. Ho,, M. S. D. L. Monte,, T. R. Rota, and, R. A. Sobel. 1986. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann. Neurol. 20: 289– 295.
99. Gelbard, H.,, H. Nottet,, K. Dzenko,, M. Jett,, P. Genis,, R. White,, L. Wang,, Y. B. Choi,, D. Zhang,, S. Lipton,, S. Swindells,, L. Epstein, and, H. Gendelman. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type-1 infection neurotoxin. J. Virol. 68: 4628– 4635.
100. Gelbard, H. A.,, K. Dzenko,, D. Diloreto,, C. D. Cerro,, M. D. Cerro, and, L. G. Epstein. 1993. Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtypes implications for AIDS neuropathogenesis. Dev. Neurosci. 15: 417– 422.
101. Gelbard, H. A.,, and L. G. Epstein. 1995. HIV-1 encephalopathy in children. Curr. Opin. Pediatr. 7: 655– 662.
102. Gendelman, H.,, and S. Gendelman. 1992. Neurological aspects of human immunodeficiency virus infection, p. 229–254. In S. Specter,, M. Bendinelli, and, H. Friedman (ed.), Neuropathogenic Viruses and Immunity. Plenum Press, New York, NY.
103. Gendelman, H. E.,, J. H. Atkinson,, I. P. Everall,, R. G. Gonzaliz,, I. Grant,, R. Heaton,, D. L. Kolson,, S. A. Lipton,, J. McArthur,, A. Nath,, C. Power,, S. Swindells, and, B. Wigdahl. 2005. Overview: a panel discussion on current and future insights into the neurological, behavioral, and motor consequences of HIV-1 infection, p. 1–11. In H. E. Gendelman,, I. Grant,, I. P. Everall,, S. A. Lipton, and, S. Swindells (ed.), The Neurology of AIDS, 2nd ed. Oxford University Press, New York, NY.
104. Gendelman, H. E.,, and D. G. Folks. 1999. Innate and acquired immunity in neurodegenerative disorders. J. Leukoc. Biol. 65: 407– 409.
105. Gendelman, H. E.,, P. Genis,, M. Jett,, Q. H. Zhai, and, H. S. Nottet. 1994. An experimental model system for HIV-1-induced brain injury. Adv. Neuroimmunol. 4: 189– 193.
106. Gendelman, H. E.,, O. Narayan,, S. Kennedy-Stoskopf,, J. E. Clements, and, G. H. Pezeshkpour. 1984. Slow virus-macrophage interactions. Characterization of a transformed cell line of sheep alveolar macrophages that express a marker for susceptibility to ovine-caprine lentivirus infections. Lab. Investig. 51: 547– 555.
107. Gendelman, H. E.,, O. Narayan,, S. Kennedy-Stoskopf,, P. G. Kennedy,, Z. Ghotbi,, J. E. Clements,, J. Stanley, and, G. Pezeshkpour. 1986. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J. Virol. 58: 67– 74.
108. Gendelman, H. E.,, O. Narayan,, S. Molineaux,, J. E. Clements, and, Z. Ghotbi. 1985. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc. Natl. Acad. Sci. USA 82: 7086– 7090.
109. Gendelman, H. E.,, Y. Persidsky,, A. Ghorpade,, J. Limoges,, M. Stins,, M. Fiala, and, R. Morrisett. 1997. The neuropathogenesis of the AIDS dementia complex. AIDS 11: S35– S45.
110. Gendelman, H. E.,, J. Zheng,, C. L. Coulter,, A. Ghorpade,, M. Che,, M. Thylin,, R. Rubocki,, Y. Persidsky,, F. Hahn,, J. Reinhard, and, S. Swindells. 1998. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178: 1000– 1007.
111. Genis, P.,, M. Jett,, E. Bernton,, T. Boyle,, H. Gelbard,, K. Dzenko,, R. Keane,, L. Resnick,, Y. Mizrachi,, D. Volsky,, L. Epstein, and, H. Gendelman. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176: 1703– 1718.
112. Ghorpade, A.,, and H. E. Gendelman. 2003. Non-neuronal cells and their interactions in AIDS-associated dementia, p. 9901–9920. In L. Hertz (ed.), Non-Neuronal Cells of the Nervous System: Function and Dysfunction. Elsevier, New York, NY.
113. Ghorpade, A.,, S. Holter,, K. Borgmann,, R. Persidsky, and, L. Wu. 2003. HIV-1 and IL-1β beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway. J. Neuroimmunol. 141: 141– 149.
114. Ghorpade, A.,, A. Nukuna,, M. Che,, S. Haggerty,, Y. Persidsky,, E. Carter,, L. Carhart,, L. Shafer, and, H. E. Gendelman. 1998a. Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J. Virol. 72: 3340– 3350.
115. Ghorpade, A.,, R. Persidskaia,, R. Suryadevara,, M. Che,, X. J. Liu,, Y. Persidsky, and, H. E. Gendelman. 2001. Mononuclear phagocyte differentiation, activation and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 75: 6572– 6583.
116. Ghorpade, A.,, Y. Persidsky,, S. Swindells,, K. Borgmann,, R. Persidsky,, S. Holter,, R. Cotter, and, H. E. Gendelman. 2005. Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects. J. Neuroimmunol. 163: 145– 156.
117. Ghorpade, A.,, M. Q. Xia,, B. T. Hyman,, Y. Persidsky,, A. Nukuna,, P. Bock,, M. Che,, J. Limoges,, H. E. Gendelman, and, C. R. Mackay. 1998b. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72: 3351– 3361.
118. Giulian, D.,, J. Yu,, L. Xia,, D. Tom,, J. Li,, S. N. Lin,, R. Schwarz, and, C. Noonan. 1996. Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain. J. Neurosci. 16: 3139– 3153.
119. Glass, J. D.,, H. Fedor,, S. L. Wesselingh, and, J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38: 755– 762.
120. Gonzalez-Scarano, F.,, and J. Martin-Garcia. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5: 69– 81.
121. Gorry, P. R.,, M. Churchill,, S. M. Crowe,, A. L. Cunningham, and, D. Gabuzda. 2005. Pathogenesis of macrophage tropic HIV-1. Curr. HIV Res. 3: 53– 60.
122. Gorry, P. R.,, J. Taylor,, G. H. Holm,, A. Mehle,, T. Morgan,, M. Cayabyab,, M. Farzan,, H. Wang,, J. E. Bell,, K. Kunstman,, J. P. Moore,, S. M. Wolinsky, and, D. Gabuzda. 2002. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J. Virol. 76: 6277– 6292.
123. Gray, L.,, J. Sterjovski,, M. Churchill,, P. Ellery,, N. Nasr,, S. R. Lewin,, S. M. Crowe,, S. L. Wesselingh,, A. L. Cunningham, and, P. R. Gorry. 2005. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 337: 384– 398.
124. Guillemin, G. J.,, S. J. Kerr, and, B. J. Brew. 2005. Involvement of quinolinic acid in AIDS dementia complex. Neurotox. Res. 7: 103– 123.
125. Guntermann, C.,, B. J. Murphy,, R. Zheng,, A. Qureshi,, P. A. Eagles, and, K. E. Nye. 1999. Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation. Biochem. Biophys. Res. Commun. 256: 429– 435.
126. Gupta, P.,, K. B. Collins,, D. Ratner,, S. Watkins,, G. J. Naus,, D. V. Landers, and, B. K. Patterson. 2002. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76: 9868– 9876.
127. Harrison, J. K.,, Y. Jiang,, S. Chen,, Y. Xia,, D. Maciejewski,, R. K. McNamara,, W. J. Streit,, M. N. Salafranca,, S. Adhikari,, D. A. Thompson,, P. Botti,, K. B. Bacon, and, L. Feng. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95: 10896– 10901.
128. Haskell, C. A.,, M. D. Cleary, and, I. F. Charo. 1999. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J. Biol. Chem. 274: 10053– 10058.
129. Haskell, C. A.,, M. D. Cleary, and, I. F. Charo. 2000. Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J. Biol. Chem. 275: 34183– 34189.
130. Haydon, P. G. 2001. GLIA: listening and talking to the synapse. Nat. Rev. Neurosci. 2: 185– 193.
131. He, J.,, Y. Chen,, M. Farzan,, H. Choe,, A. Ohagen,, S. Gartner,, J. Busciglio,, X. Yang,, W. Hofmann,, W. Newman,, C. R. Mackay,, J. Sodroski, and, D. Gabuzda. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645– 649.
132. Heese, K.,, C. Hock, and, U. Otten. 1998. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70: 699– 707.
133. Hesselgesser, J.,, M. Halks-Miller,, V. DelVecchio,, S. C. Peiper,, J. Hoxie,, D. L. Kolson,, D. Taub, and, R. Horuk. 1997. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7: 112- 121.
134. Hesselgesser, J.,, and R. Horuk. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5: 13– 26.
135. Hesselgesser, J.,, M. Liang,, J. Hoxie,, M. Greenberg,, L. F. Brass,, M. J. Orsini,, D. Taub, and, R. Horuk. 1998a. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J. Immunol. 160: 877– 883.
136. Hesselgesser, J.,, D. Taub,, P. Baskar,, M. Greenberg,, J. Hoxie,, D. L. Kolson, and, R. Horuk. 1998b. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1alpha mediated by the chemokine receptor CXCR4. Curr. Biol. 8: 595– 598.
137. Heyes, M. P.,, B. B. Brew,, A. Martin,, R. W. Price,, A. Salazar,, J. J. Sidtis,, J. A. Yergey,, M. M. Mouradian,, A. E. Sadler,, J. Keilp,, R. Rubinow, and, S. P. Markey. 1991. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29: 202– 209.
138. Hofman, F. M.,, P. Chen,, F. Incardona,, R. Zidovetzki, and, D. R. Hinton. 1999. HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J. Neuroimmunol. 94: 28– 39.
139. Holm, G. H.,, and D. Gabuzda. 2005. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J. Virol. 79: 6299– 6311.
140. Horuk, R.,, J. Hesselgesser,, Y. Zhou,, D. Faulds,, M. Halks-Miller,, S. Harvey,, D. Taub,, M. Samson,, M. Parmentier,, J. Rucker,, B. J. Doranz, and, R. W. Doms. 1998. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem. 273: 386– 391.
141. Horuk, R.,, A. W. Martin,, Z. Wang,, L. Schweitzer,, A. Gerassimides,, H. Guo,, Z. Lu,, J. Hesselgesser,, H. D. Perez,, J. Kim,, J. Parker,, T. J. Hadley, and, S. C. Peiper. 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 158: 2882– 2890.
142. Huang, E. J.,, and L. F. Reichardt. 2003. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72: 609– 642.
143. Hulshof, S.,, E. S. van Haastert,, H. F. Kuipers,, P. J. van den Elsen,, C. J. De Groot,, P. van der Valk,, R. Ravid, and, K. Biber. 2003. CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J. Neuropathol. Exp. Neurol. 62: 899– 907.
144. Imai, T.,, K. Hieshima,, C. Haskell,, M. Baba,, M. Nagira,, M. Nishimura,, M. Kakizaki,, S. Takagi,, H. Nomiyama,, T. J. Schall, and, O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521– 530.
145. Imai, Y.,, T. Kimura,, A. Murakami,, N. Yajima,, K. Sakamaki, and, S. Yonehara. 1999. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398: 777– 785.
146. Janssen, R.,, D. Cornblath,, L. Epstein,, R. Foa,, J. McArthur,, R. Price,, A. Asbury,, A. Beckett,, D. Benson,, T. Bridge,, C. Levanthal,, P. Satz,, A. Saykin,, J. Sidtis, and, S. Tross. 1991. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Neurology 41: 778– 785.
147. Jiang, Z.,, C. Piggee,, M. P. Heyes,, C. Murphy,, B. Quearry,, M. Bauer,, J. Zheng,, H. E. Gendelman, and, S. P. Markey. 2001. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117: 97– 107.
148. Joly, M.,, and J. M. Pinto. 2005. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1. Math Biosci. 195: 92– 126.
149. Jones, M.,, K. Olafson,, M. R. Del Bigio,, J. Peeling, and, A. Nath. 1998. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57: 563– 570.
150. Jung, S.,, J. Aliberti,, P. Graemmel,, M. J. Sunshine,, G. W. Kreutzberg,, A. Sher, and, D. R. Littman. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20: 4106– 4114
151. Kadiu, I.,, J. G. Glanzer,, J. Kipnis,, H. E. Gendelman, and, M. P. Thomas. 2005. Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox. Res. 8: 25– 50.
152. Kalehua, A. N.,, J. E. Nagel,, L. M. Whelchel,, J. J. Gides,, R. S. Pyle,, R. J. Smith,, J. W. Kusiak, and, D. D. Taub. 2004. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp. Cell Res. 297: 197– 211.
153. Kastenbauer, S.,, U. Koedel,, M. Wick,, B. C. Kieseier,, H. P. Hartung, and, H. W. Pfister. 2003. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J. Neuroimmunol. 137: 210– 217.
154. Kaul, M. 2008. HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci. 13: 2484– 2494.
155. Kaul, M.,, and S. A. Lipton. 2006. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J. Neuroimmune Pharmacol. 1: 138– 151.
156. Kaul, R.,, J. Rutherford,, S. L. Rowland-Jones,, J. Kimani,, J. I. Onyango,, K. Fowke,, K. MacDonald,, J. J. Bwayo,, A. J. McMichael, and, F. A. Plummer. 2004. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. AIDS 18: 2087– 2089.
157. Kedzierska, K.,, and S. M. Crowe. 2002. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9: 1893– 1903.
158. Kelder, W.,, J. C. McArthur,, T. Nance-Sproson,, D. McClernon, and, D. E. Griffin. 1998. β-Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 44: 831– 835.
159. Kerr, S. J.,, P. J. Armati,, G. J. Guillemin, and, B. J. Brew. 1998. Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 12: 355– 363.
160. Khan, M. Z.,, R. Brandimarti,, J. P. Patel,, N. Huyn,, J. Wang,, Z. Huang,, A. Fatatis, and, O. Meucci. 2004. Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis. AIDS Res. Hum. Retrovir. 20: 1063– 1071.
161. Kieburtz, K.,, and R. Schiffer. 1989. Neurologic manifestations of human immunodeficiency virus infections. Neurol. Clin. 7: 447– 468.
162. Kitai, R.,, M. L. Zhao,, N. Zhang,, L. L. Hua, and, S. C. Lee. 2000. Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta. J. Neuroimmunol. 110: 230– 239.
163. Klein, R.,, K. Williams,, X. Alvarez-Hernandez,, S. Westmoreland,, T. Force,, A. Lackner, and, A. Luster. 1999. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J. Immunol. 163: 1636– 1646.
164. Koenig, S.,, H. E. Gendelman,, J. M. Orenstein,, M. C. D. Canto,, G. H. Pezeshkpour,, M. Yungbluth,, F. Janotta,, A. Aksamit,, M. A. Martin, and, A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089– 1093.
165. Kornbluth, R. S.,, K. Kee, and, D. D. Richman. 1998. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc. Natl. Acad. Sci. USA 95: 5205– 5210.
166. Kouba, M.,, M. V. Anetti,, X. Wang,, M. Schafer, and, V. Hollt. 1993. Cloning of a novel putative G-protein-coupled receptor (NLR) which is expressed in neuronal and lymphatic tissue. FEBS Lett. 321: 173– 178.
167. Kramer-Hammerle, S.,, I. Rothenaigner,, H. Wolff,, J. E. Bell, and, R. Brack-Werner. 2005. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111: 194– 213.
168. Krathwohl, M. D.,, and J. L. Kaiser. 2004. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22: 109– 118.
169. Krebs, F. C.,, H. Ross,, J. McAllister, and, B. Wigdahl. 2000. HIV-1-associated central nervous system dysfunction. Adv. Pharmacol. 49: 315– 385.
170. Kullander, K.,, A. Kylberg, and, T. Ebendal. 1997. Specificity of neurotrophin-3 determined by loss-of-function mutagenesis. J. Neurosci. Res. 50: 496– 503.
171. Kure, K.,, K. M. Weidenheim,, W. D. Lyman, and, D. W. Dickson. 1990. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol. 80: 393– 400.
172. Kutsch, O.,, J. Oh,, A. Nath, and, E. N. Benveniste. 2000. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74: 9214– 9221.
173. Lackner, A. A.,, P. Vogel,, R. A. Rames,, D. Kluge, and, M. Marthas. 1994. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am. J. Pathol. 145: 428– 439.
174. Lavi, E.,, J. M. Strizki,, A. M. Ulrich,, W. Zhang,, L. Fu,, Q. Wang,, M. O'Connor,, J. A. Hoxie, and, F. Gonzalez-Scarano. 1997. CXCR-4 (fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1) is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 151: 1035– 1042.
175. Lazarov-Spiegler, O.,, O. Rapalino,, G. Agranov, and, M. Schwartz. 1998a. Restricted inflammatory reaction in the CNS: a key impediment to axonal regeneration? Mol. Med. Today 4: 337– 442.
176. Lazarov-Spiegler, O.,, A. S. Solomon, and, M. Schwartz. 1998b. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia 24: 329– 337.
177. Lazarov-Spiegler, O.,, A. S. Solomon,, A. B. Zeev-Brann,, D. L. Hirschberg,, V. Lavie, and, M. Schwartz. 1996. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10: 1296– 1302.
178. Letendre, S. L.,, E. R. Lanier, and, J. A. McCutchan. 1999. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J. Infect. Dis. 180: 310– 319.
179. Liapi, A.,, J. Pritchett,, O. Jones,, N. Fujii,, J. G. Parnavelas, and, B. Nadarajah. 2008. Stromal-derived factor-1 signalling regulates radial and tangential migration in the developing cerebral cortex. Dev. Neurosci. 30: 117– 131.
180. Limoges, J.,, Y. Persidsky,, L. Poluektova,, J. Rasmussen,, W. Ratanasuwan,, M. Zelivyanskaia,, D. McClernon,, E. Lanier, and, H. Gendelman. 2000. Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice. Neurology 54: 379– 389.
181. Liou, L. Y.,, C. H. Herrmann, and, A. P. Rice. 2004. HIV-1 infection and regulation of Tat function in macrophages. Int. J. Biochem. Cell Biol. 36: 1767– 1775.
182. Lipton, S. 1994. HIV coat protein gp120 induces soluble neurotoxins in culture medium. Neurosci. Res. Commun. 15: 31– 37.
183. Lipton, S. A.,, and H. E. Gendelman. 1995. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 16: 934– 940.
184. Liu, H.,, Y. Hwangbo,, S. Holte,, J. Lee,, C. Wang,, N. Kaupp,, H. Zhu,, C. Celum,, L. Corey,, M. J. McElrath, and, T. Zhu. 2004. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing noninte-grin in seronegative individuals repeatedly exposed to HIV-1. J. Infect. Dis. 190: 1055– 1058.
185. Liu, R.,, W. A. Paxton,, S. Choe,, D. Ceradini,, S. R. Martin,, R. Horuk,, M. E. MacDonald,, H. Stuhlmann,, R. A. Koup, and, N. R. Landau. 1996a. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367– 377.
186. Liu, X.,, C. N. Kim,, J. Yang,, R. Jemmerson, and, X. Wang. 1996b. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147– 157.
187. Liu, Y.,, X. P. Tang,, J. C. McArthur,, J. Scott, and, S. Gartner. 2000. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J. Neurovirol. 6 (Suppl. 1) : S70– S81.
188. Lu, M.,, E. A. Grove, and, R. J. Miller. 2002. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. USA 99: 7090– 7095.
189. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436– 445.
190. Ma, M.,, and A. Nath. 1997. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71: 2495– 2499.
191. Mackay, C. R. 1996. Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184: 799– 802.
192. Maclean, A. G.,, G. E. Belenchia,, D. N. Bieniemy,, T. A. Moroney-Rasmussen, and, A. A. Lackner. 2005. Simian immunodeficiency virus disrumpts extended lengths of the blood-brain barrier. J. Med. Primatol. 34: 237– 242.
193. Magnuson, D. S.,, B. E. Knudsen,, J. D. Geiger,, R. M. Brownstone, and, A. Nath. 1995. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37: 373– 380.
194. Marder, K.,, S. Albert,, G. Dooneief,, Y. Stern,, G. Ramachandran, and, L. Epstein. 1996. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology 47: 1247– 1253.
195. Mattson, M. P.,, N. J. Haughey, and, A. Nath. 2005. Cell death in HIV dementia. Cell Death Differ. 12 (Suppl. 1) : 893– 904.
196. McArthur, J. C.,, N. Sacktor, and, O. Selnes. 1999. Human immunodeficiency virus-associated dementia. Semin. Neurol. 19: 129– 150.
197. McManus, C. M.,, K. Weidenheim,, S. E. Woodman,, J. Nunez,, J. Hesselgesser,, A. Nath, and, J. W. Berman. 2000. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am. J. Pathol. 156: 1441– 1453.
198. Meucci, O.,, A. Fatatis,, A. A. Simen, and, R. J. Miller. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97: 8075– 8080.
199. Michael, N. L. 2002. Chemokine receptors as HIV-1 coreceptors, p. 75–91. In T. R. O'Brien (ed.), Chemokine Receptors and AIDS. Marcel Dekker, Inc., New York, NY.
200. Miller, R. 2005. Chemokines, HIV-1, and the central nervous system, p. 181–191. In H. E. Gendelman,, I. Grant,, I. P. Everall,, S. A. Lipton, and, Susan Swindells (ed.), The Neurology of AIDS, 2nd ed. Oxford University Press, New York, NY.
201. Miller, R. J.,, and O. Meucci. 1999. AIDS and the brain: is there a chemokine connection? Trends Neurosci. 22: 471– 479.
202. Minami, M.,, and M. Satoh. 2000. Chemokines as mediators for intercellular communication in the brain. Nippon Yakurigaku Zasshi 115: 193– 200.
203. Miyauchi, K.,, J. Komano,, Y. Yokomaku,, W. Sugiura,, N. Yamamot, and, Z. Matsuda. 2005. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 79: 4720– 4729.
204. Mizuno, T.,, J. Kawanokuchi,, K. Numata, and, A. Suzumura. 2003. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 979: 65– 70.
205. Nath, A.,, K. Conant,, P. Chen,, C. Scott, and, E. O. Major. 1999. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 274: 17098– 17102.
206. Nath, A.,, and J. Geiger. 1998. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54: 19– 33.
207. Nath, A.,, K. Psooy,, C. Martin,, B. Knudsen,, D. Magnuson,, N. Haughey, and, J. D. Geiger. 1996. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70: 1475– 1480.
210. New, D. R.,, M. Ma,, L. G. Epstein,, A. Nath, and, H. A. Gelbard. 1997. Human immunodeficiency virus type-1 tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3: 168– 173.
211. New, D. R.,, S. B. Maggirwar,, L. G. Epstein,, S. Dewhurst, and, H. A. Gelbard. 1998. HIV-1 Tat induces neuronal death via tumor necrosis factor alpha and activation of non-NMDA receptors by a NFkB-independent mechanism. J. Biol. Chem. 273: 17852– 17858.
212. Ni, H. T.,, S. Hu,, W. S. Sheng,, J. M. Olson,, M. C. Cheeran,, A. S. Chan,, J. R. Lokensgard, and, P. K. Peterson. 2004. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res. Dev. Brain Res. 152: 159– 169.
213. Nishimura, Y.,, C. R. Brown,, J. J. Mattapallil,, T. Igarashi,, A. Buckler-White,, B. A. Lafont,, V. M. Hirsch,, M. Roederer, and, M. A. Martin. 2005. Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc. Natl. Acad. Sci. USA 102: 8000– 8005.
214. Nottet, H. S.,, and H. E. Gendelman. 1995. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol. Today 16: 441– 448.
215. Nottet, H. S.,, M. Jett,, C. R. Flanagan,, Q. H. Zhai,, Y. Persidsky,, A. Rizzino,, E. W. Bernton,, P. Genis,, T. Baldwin,, J. H. Schwartz,, C. J. LaBenz, and, H. E. Gendelman. 1995. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154: 3567– 3581.
216. Nottet, H. S.,, Y. Persidsky,, V. G. Sasseville,, A. N. Nukuna,, P. Bock,, Q. H. Zhai,, L. R. Sharer,, R. D. McComb,, S. Swindells,, C. Roderland, and, H. E. Gendelman. 1996. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156: 1284– 1295.
217. Oberlin, E.,, A. Amara,, F. Bachelerie,, C. Bessia,, J. L. Virelizier,, F Arenzana-Seisdedos,, O. Schwartz,, J. M. Heard,, I. Clark-Lewis,, D. F. Legler,, M. Loetscher,, M. Baggiolini, and, B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833– 835.
218. O'Brien, T. R.,, N. L. Michael,, H. W. Sheppard, and, S. Buchbinder. 2002. HIV-1 infection in patients with the CCR5-Δ32 homozygous genotype, p. 215– 225. In T. R. O'Brien (ed.), Chemokine Receptors and AIDS. Marcel Dekker, Inc., New York, NY.
219. Ohagen, A.,, S. Ghosh,, J. He,, K. Huang,, Y. Chen,, M. Yuan,, R. Osathanondh,, S. Gartner,, B. Shi,, G. Shaw, and, D. Gabuzda. 1999. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J. Virol. 73: 897– 906.
220. Pandey, V.,, and S. R. Bolsover. 2000. Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor. Biochem. Biophys. Res. Commun. 274: 212– 215.
221. Perno, C. F.,, S. Aquaro,, B. Rosenwirth,, E. Balestra,, P. Peichl,, A. Billich,, N. Villani, and, R. Calio. 1994. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J. Leukoc. Biol. 56: 381– 386.


Last edited by High Springs Gator; 02-06-2008 at 03:42 AM..
It's only cheap for the employers of illegals. Everyone else pays the difference.
Why didn't you ask the last preznit?
Heck, you even had two chances with that guy.
It's not the "preznit" that really has the say in these things. Obviously, all of these things are being solved by individual states now, since the federal government (all branches) has no balls.
Illegal immigrants don't come cheap? Well, they sure come cheap enough for Mitt Romney to hire them to work on his plantation.
they are cheap to him. It is the rest of us who have to shoulder the bill. Since you live in DC, you should see Seven Corners and Bailey's Crossroads in VA to see how we are paying for it.
For the umpteenth time, Mitt Romney didn't hire illegal aliens. He hired a landscaping company. The landscaping company hired the illegals. Here in America we don't go running out of our kitchens demanding documentation of citizenship from people who look Hispanic or speak a different language.
And I don't even LIKE Romney, but this accusation really needs to be put to rest.
...apologists must think there's some distinction other people just can't see.
The Mitt was outed, he knew there were illegals working for him and he didn't do anything about it till it was publicized.
It wasn't until after it was publicized that he decided, (or maybe his handlers told him to), take a stand.
As someone who is STRONGLY anti-illegal immigration, I should probably be riding front and center to castigate Mitt for his faux pas at the Governor's Mansion, especially considering that he's not even 'my' candidate, but I think it's important to be able to see the forest AND the trees.
Let's say, for instance, that Mitt ran out to the yard demanding to see proof of citizenship from his Spanish-speaking landscape crew. Can you imagine how fast he'd have been hit with a civil rights suit? My guess is that you'd be calling for his head, also.
Which makes him "Damned if he did, damned if he didn't."
Section 8 is clear:CHA determines eligibility based on U.S. citizenship or eligible immigration status.
In NC, You qualify for Health Insurance not only because you are under a certain income but you also need to have a valid Social Security number or have an eligible immigration status.
There is NOT an "earned income credit" when you don't have a valid Social Security number.
Free meals at school... I mean come on, they are CHILDREN! Did your parents teached you anything!


text:
Blood from umbilical cord used to treat cerebral palsy
Oliver Moody, Science Correspondent
March 5 2018, 12:01am, The Times
Shilpa and Raj Shetty with their sons Jay, left, who has cerebral palsy, and Kairav, whose stem cells will be usedBEN GURR FOR THE THE TIMES
Children with autism, cerebral palsy and four other neurological conditions are being given infusions of umbilical cord blood in a controversial experiment in America.
Over the past decade more than 700 young patients with "brain injuries" have received stem cells, which had been frozen and banked at birth, during clinical trials at Duke University Medical Center in North Carolina.
Medical authorities in the US have now given the scientists permission to offer the treatment to families from around the world, including the UK.
While some of the patients' symptoms may have improved, other experts say that the results are flawed and that it is unclear how the therapy can help such a spectrum of conditions.
The treatment is at the centre of a debate about…

redpajama_set_name: RedPajamaCommonCrawl


Momsen was conceived in (July 26, 1993) St. Louis, Missouri. Her folks are Michael and Collette Momsen and she has a more youthful sister, Sloane Momsen, who is additionally an on-screen character. She has Russian parentage. She was raised Roman Catholic and went to Our Lady of Lourdes Catholic School for primary school and later Herbert Hoover Middle School in Potomac, Maryland. She considered move at the Center of Creative Arts in St. Louis.
Momsen was marked with Ford Models at an exceptionally youthful age: "My folks marked me up with Ford [Modeling] at 2 years old. No 2-year-old needs to work, yet I had no way out. My entire life, I was in and out of school. I didn't have companions. I was working continually and I didn't have a genuine life."She started acting professionally at three years old in a 1997 national business for Shake 'n Bake. She was then thrown in The Prophet's Game.
Momsen is incorporated on the rundown of Unclaimed Coogan represents performing kids whose incomplete youth profit are ordered to be placed in a unique store yet who still can't seem to assert their income.
Momsen went to the Professional Performing Arts School in Manhattan for secondary school close by Connor Paolo, Gregori Lukas and Sarah Hyland.


Every day, you have rooms to fill and spend money heating and cooling rooms–regardless if they're filled. The cost of replacing older, inefficient windows can be out of the budget and can change the architectural integrity of the building. Behind labor, utilities represent the largest variable cost to the hotel operator. Reduction of noise from street traffic, sirens and wind is best in class and will be the best side effect of this system to your guests. Thermolite Window Systems is the solution and will install from the inside in our typical clandestine fashion.


text:
Battlestar Stock Video Footage
VInA DEL MAR, CHILE - MILITARY BOAT - A Chilean marine speedboat races towards the camera in front a large cargo ship.
Animated spaceship hangar green screen video footage
Flythrough NASA International Space Station (ISS) spaceship shuttle interior, 3d animation of sci-fi corridor excellent to use in any project that relates to space adventure and sci-fi travel
Location Track of American Aircraft Carrier, Satellite Spy Camera Screen, Close Up
Universal Studio, Singapore - MARCH 8, 2019 : Roller coaster in Universal Studios Singapore at Singapore Resorts World Sentosa.
Gunboat
VInA DEL MAR, CHILE - MILITARY BOAT - A Chilean marine speedboat floats on the water in the bay.
NEW YORK CITY - APRIL 21: US Coast Guard Warship at the New York Harbor. April 21, 2012 in NYC, New York, USA
Singapore. November 23, 2017: Video footage of Universal Studios Singapore with Battlestar Galactica roller coaster
Singapore. November 23, 2017: Video footage of Battlestar Galactica roller coaster in Sentosa Island Singapore
Singapore. November 23, 2017: Video footage of Battlestar Galactica roller coaster in the Universal Studios Singapore
Universal Studio Singapore, Singapore - MARCH 8, 2019 : Statue of actors and directors in Universal Studio Singapore is a theme park located within Resorts World Sentosa on Sentosa Island, Singapore.
Singapore, Singapore - 01 06 2018: Drone flight of Universal Studios Singapore
VInA DEL MAR, CHILE - MILITARY BOAT - A Chilean marine speedboat races across the water near the shore.
VInA DEL MAR, CHILE - MILITARY BOAT - A Chilean marine speedboat races across the water in the bay.
SEVASTOPOL, UKRAINE - SEPTEMBER 07: Warship & the President yacht "Crimea" in Balaklava bay. September 07, 2012 in Sevastopol, Crimea, Ukraine.
The most searched stock video in battlestar category:


Brisbane-based Tangren Cultural Film Group has acquired multinational company Asia Releasing, a distributor and marketing firm specializing in the handling of Chinese films. Milt Barlow, industry veteran and Asia Releasing founder, will stay on as COO of Tangren.
Tangren has quickly built up a 60% market share of the box office for Chinese and Korean movies in Australia. It recently released "Along With the Gods 1 & 2," China's "Operation Red Sea" and "How Long Will I Love You." The company has a current slate of 25 to 30 films for the next year, in Australia, New Zealand, North America and the U.K.
Tangren expects to have a major presence at this year's American Film Market in November. It will open a North American hub in Los Angeles in the first months of 2019 and is evaluating other markets.
Previously president and CEO of Village Roadshow Entertainment, Barlow was a co-founder and CEO of China Lion, which helped open up the market for contemporary Chinese films in English-speaking territories. Barlow was one of the pioneers of day-and-date releasing of mainstream Chinese movies to Chinese diaspora audiences in the West. He released his first Chinese-language movie, "Ip Man," in 2008 , in New Zealand.


text:
Iran says to receive ATR planes 'within days'
Press TV – Iran says it expects to receive the first batch of planes from European aviation player ATR within the next few days.
Iran's Deputy Minister of Road and Urban Development for International Affairs Asghar Fakhrieh Kashan told the domestic media that four ATR planes would arrive in the country before Friday.
Fakhrieh Kashan told the country's state news agency IRNA that five more planes would be handed over to Iran until the end of 2017. However, he did not provide a clear timetable for the deliveries.
All the planes would be delivered to Iran's national flag-carrier airline Iran Air, IRNA added.
In April, Iran Air finalized an agreement with ATR to buy 20 planes from the company at an estimated cost of above $500 million.
The planes – all ATR 72-600 – would be twin-propeller aircraft that can carry 70 passengers.
Iran Air Managing Director Farhad Parvaresh told reporters in Tehran last month that his company had an option to purchase another 20 planes from the French-Italian company.
On the same front, Iran's Minister of Roads and Urban Development Abbas Akhoundi was quoted by the domestic media as saying in April that ATR planes would be mostly used for flights to Iran's small airports.
Akhoundi emphasized that providing small- to medium-range planes like those produced by ATR played a central role in the government's plan to rejuvenate Iran's air transportation fleet.
Iran's plans to purchase planes from the France-based company comes after Iran struck deals with European aviation giant Airbus and the US aviation company Boeing in 2016 to purchase about 180 jets.
The agreements came after the restrictions imposed on Iran's aviation industry were lifted following a nuclear deal, known as the Joint Comprehensive Plan of Action (JCPOA).
#IranDeal, Asghar Fakhrieh Kashan, ATR aircraft manufacturer, JCPOA	May 15, 2017
Iran to import shipbuilding technology from South Korea: Official
Iran English language newspaper headlines on Monday, 15-05-2017


text:
Design the life you want
Sudha's goosebump moment
Greetings! Nepal
Design the life you want according to Orison Swett Marden – Sudha's goosebumpmoment
Sudha: "Hi, I am from Nepal. My goosebumpmoment is when I think I was around 16-17 and I read these books of Swett Marden and what was written there not only gave me goosebumps, but it transformed my life. So, what was written there was "You are the creator of your own destiny, you are the driver of this vehicle called life, you are the captain of this ship called life and you can take it to the direction you want, you don't need to follow the crowd". So, you know, it was groundbreaking, it was life changing because before that we weren't taught in school like you can really choose your life, we were living on autopilot, you know, doing whatever everyone was doing like following the society. But it was like, okay, now I can create my own life. It really transformed my life. So, that was one of the biggest moments in my life. It gave me goosebumps and transformed my life like I am really a creator of my life right now. Thank you."
Orison Swett Marden, an inspiring author
The books of Orison Swett Marden, considered one of the fathers of personal development, have inspired entire generations. His works, which speak about success, failure and the great power of moving forward when circumstances are not favourable, inspire us to have confidence in ourselves.
And even though hhe grew up in the midst of many adversities, Swett Marden's life was a remarkable example of faith, perseverance, and optimism that inspires us to successfully accomplish all that we set out to do in our lives.
A man with great resilience
Although his life was not easy as a child after being orphaned at age 7 and living with 5 different host families, Orison Swett Marden was a highly resilient person who helped thousands of people succeed. This author, born in the United States in 1850, is considered one of the founding fathers of the philosophy of self-help and self-improvement in America.
Due to his difficult situation, he began to read self-help books and these inspired him to escape the world of poverty and become self-sufficient. Despite all the challenges he faced, he enrolled at Boston University and managed to graduate in 1871.
In order to pay for his studies, Marden founded the Boston University Club, a food club for teachers and students. It became a success and after this achievement, the president of Harvard University called him to create another club at his university.
Thanks to his great skills in business management, he started working as a hotel manager. Later, with the money earned, he would buy his own hotel. However, during the Great Depression, he lost ownership of the many hotels and resorts that he owned. He soon began working as a hotel manager in Chicago.
When the crisis took away his hotels, he rented a room in a stable and began to write his first manuscript. This manuscript contained 1000 pages and one day, before its completion, it was burned by a fire that broke out in the stable where he lived. Instead of giving up, he decided to rewrite it. He had a burning desire to finish it and no difficulty would prevent him from achieving his goal.
When he tried to get publishers to publish his work, he faced many rejections, since the United States was in the third year of the Depression and there was no money in the country. After many rejections, in 1894, his book "Pushing the Front" was published. This book was well received at a time when a bit of motivation was needed more than ever.
In 1897 Marden founded the magazine "Success", which dealt with personal achievements. Some of the most influential people in the field of personal improvement participated in it, such as: Og Mandino, Napoleon Hill and W. Clement Stone.
He finally retired in 1924, and together with his wife, he retired to Los Angeles to start a new life. Shortly after his arrival, however, Orison passed away.
The success of Orison Swett Marden
Orison Swett Marden wrote more than 60 books in a 30-year period without a word processor, just with a typewriter.
Marden succeeded in all his endeavours because he was a student who put his knowledge to work. Through his religious beliefs, he literally practiced what he preached. His genius allowed him to go into business, capture publishing opportunities, study all aspects of life, and even become a speaker and writer. His success came from putting all of those positive elements and accomplishments into action.
More about Orison Swett Marden:
How to find oneself according Orison Swett Marden
Orison Swett Marden- Biography
Orison Swett Marden – The cure for those who are discouraged
Making Life a Masterpiece by Orison Swett Marden


Whenever I felt frightened about a new venture, my mother would share her favorite quote by Franklin Roosevelt " The only thing we have to fear is fear itself". That has stayed with me through many a scary time. It made so much sense but unfortunately I think the times have created a new metaphor around fear. Essentially, we are now in the midst of a culture that seems to love to dole out fear as if it were candy for the masses.
Not a day goes by without some news that informs us that we must avoid something that might be detrimental to our well being. If you watch any of the 24 hour news channels, you're more than likely to discover something frightening every few minutes. Even if the anchor person is discussing a subject that is somewhat tepid, you can rest assured that they'll be a scroll underneath them reporting on a murder or a new salmonella scare. Our bodies are programmed to help us to "fight or flee" if we are under siege. This mechanism is at the ready whether it is real or imagined.
If our perceptions are such that we feel under attack many times during the day, the constant flooding of cortisol throughout our systems will eventually damage our bodies ability to keep its' immune system intact. It will also make us anxious and or depressed. In today's world the media seems focused on scaring the living hell out of us as a form of entertainment. This segue ways into every nook and cranny of our lives. Eating a meal with friends or family has become riddled with dialogue about whether the ingredients are healthy or harmful. One day we hear blueberries could lead us to the promised land the next we are on the road to damnation.
Children are so protected that the days of seeing them running around outdoors is becoming practically extinct. It could make the national news if someone sights a group of kids playing kickball in the streets without helmets, kneepads and an emergency medical kit close at hand. Talking to a stranger in a line at the grocery store might kill you if they have the slightest sniffle and you had better reflect on your behavior if you talk too much, flush the toilet too many times or have a need to call your mother too often. Maybe it's time to stop feeding the piranhas of fear. Information can be useful or useless. It's up to you to sort it out. Use it wisely and don't become its' slave.
Buyer Beware:If it's too good to be true, leave it on the shelf.
Last week I read an article in the newspaper that made me strut around the house yelling " AT LAST"!
What brought me to such a euphoric state? Well it wasn't the discovery of a drug for woman comparable to Viagra, but rather an announcement that the FDA made that they were going to take a far more aggressive role over deceptive ad practices.
One of their first targets is the worlds' biggest yogurt maker Dannon, who agreed to pay a $21million fine and stop making exaggerated health claims for two popular Dannon products. Marion Nestle, a New York University nutritionist stated that "The claims aren't about health, they're about marketing". DUH! I've been ranting about how absurd the notion that a food product has been developed with so many magical health properties for years.
Activia is supposed to cure "irregularity" which is the latest problem that seems to effect a great majority of Americans. It used to be called constipation, but I guess that's too harsh a word. When did this start and why are so many afflicted with this problem, and why do they have to buy a specific product for their situation?
Well it sells because it contains probiotics, a beneficial bacteria for the colon, but so do most yogurts. It also contains 19 grams of sugar which means it has it has over four teaspoons in a four ounce container. Aren't we supposed to be more aware of sugar content? So now you become regular but you get diabetes? Makes sense to me.
What about beans? Lots of fiber and cheap. I just got five 15 ounce cans for 4 dollars. We all know about the power of the bean, yet there are no cutesy commercials touting their benefits with a movie star as a spokesperson sharing the great outcome they got from eating beans. There's not even an animated bean dressed in spandex jeans circling around a group of constipated adults sharing the latest research on beans and their benefits.
Do you think lifestyle might have an impact on irregularity, like lack of exercise, very little sleep and too much stress? When you're stressed out your intestines suffer big time. It's hard to get anything to pass through.
Aside from the above, the most important message we should take away from the latest food fiasco is "buyer beware". If it's too good to be true, leave it on the shelf.


Lafayette resident. Son of Sally and Judge Adrian G. Duplantier. Married to the former Susan Rabalais. Three children, Marcel, Caroline and Jacques.
District Court Judge, 15th Judicial District Court, October 1992. Parishes of Lafayette, Acadia and Vermilion.


text:
Gonospira funicula е вид коремоного от семейство Streptaxidae.

Разпространение
Видът е разпространен в Реюнион.

Източници

Gonospira

redpajama_set_name: RedPajamaWikipedia


This week at Starbucks restored my faith in humanity, and my enjoyment of the job. I won't lie- it's been rough at work lately. Labor must be kept under sale volume, which means that we are understaffed most of the day, every day. Then the holidays hit, and we were dealing with extra merchandise in the back room, extra drinks to throw in the mix, and customers with about as much patience as a stick of lit dynamite. Once the holidays were over, we obsessed about our white-glove cleaning inspection, where so much as one coffee bean out of place would earn an "excessive dirt build-up" rating (and yes, I am serious about just one solitary bean out of place).
This week, things calmed down. We still had our crazy "line to the door" times, but in between those moments were moments of pure peace. We could actually focus on issues, we could tidy up the café, we could restock merchandise.
You know what? It made us nicer people. At one point, mid afternoon, our café was completely empty for 20 minutes. Hmmm, what to do? How about we put on the Jazz Crooners, crank up the music, and belt out The Look of Love while sweeping up crumbs and wiping up spills? Oh yes, that will work!
Customers noticed the difference. Soon after our little singing session, we had a customer come in and order a Venti Breve Latte. I was on bar, and unconsciously called the drink back to the register partner in iambic senarius (try it yourself, daDA daDA daDA). The customer cracked up, and stayed for another ten minutes telling us funny stories about how snooty baristas usually are at other stores, and how nice it was to see baristas having fun with their job. That's when it hit me- we were having fun again!
So the next time you go into a Starbucks and the partners are less than stellar (ha! See what I did there?), just keep in mind that they might be stressed out of their minds. It's not an excuse, but it is a reason. I'm hoping, though, that our less-stressful atmosphere will continue for a while- I like having fun at work!
I'm missing a library book.
Wait, stop! Please don't pass out!
Okay now? Good; I'll move on.
What I find amazing is that if I go buy the same book as I lost for the library with the same ISBN, it'll cost me about $6. Seriously, and that's for a new copy. They, however, want me to pay $16 dollars to replace the book, with no guarantee that they'll get a new copy to replace the one I can't find. They can make $10 or more on this transaction! Arg.
But this post is not meant to focus on my inability to organize. No, this post is on the ridiculousness of libraries. First off, library fines don't go straight back into the library budget. They instead go into the city coffers. I have a bit of an issue with that. If I get a speeding ticket, then I expect my money to go to the city. If my book is a little late, then I expect my money to go to the library.
Apparently, this is a tough concept for the city to handle. Or maybe not.
Before I delve too deeply into this mess, allow me to confess that I am not a business-type person. I don't fully understand the workings of city government, and all the information I have is gleaned from conversations with librarians and a PowerPoint that you are free to view for yourself here. But never fear, dear readers, this ignorance will not stop me from expressing my opinion.
Our city, by its own admission, has higher library fines than average. More to the point, its fines are much higher than the cities surrounding it. According to data from 2007 (not great, I know, but it's the most recent I could find), other cities are between $.10-.15 per item. We are at $.20.
Now for the big numbers. Annually, residents pay somewhere in the neighbourhood of $300,000 yearly in fines. Now that I see those numbers, my $16 seems so insignificant. Wow, $300,000? That's a lot of late books/movies/cds!
This is the part where my head begins to hurt. Library fines (which I've been told don't go directly to the library), only make up 2% of the annual library budget. Breathe for a moment and soak up that information. Our libraries have a 15 million dollar budget? They don't seem to buy all that many new materials, so I'm assuming that the bulk of that goes to building upkeep and salaries. It may look like a lot of money, but then realize you are spreading that out among 10 buildings. Not such a liberal budget after all. Anyway. It is also 13% of book purchasing yearly- sorry, but doing that math makes my head hurt. Feel free to work out what the annual book buying budget is and post it in the comments!
So, if I have this right (and again, I might not), the fines we pay make up 2% of the total budget, and that 2% of the budget only cover 13% of book buying costs. Is anyone else having flashbacks to high school Algebra word problems? Then we will quickly move on.
I shouldn't be. According to my source material, 454 accounts in 2007 had fines amounting to more than $72,000. At first I thought that all 454 accounts added up to $72,000, with the average account having a $158 total fine. No, apparently these are individual accounts with $72,000 each. I don't know if that is even possible, but unless the slides are poorly written that's what they say. That would make outstanding fines over $32.5 million, and that seems unreasonable to me. Maybe it is the $158 instead, but who knows?
Here's my problem- if our yearly library budget is $15 million (and again, math is not my strong suit), and the city managed to collect the some $30 million in unpaid fines (we are still very hypothetical here), that extra money would not go to the library. Instead, that money would go to the city coffers, $15 million would go to the Library budget (making Library fines support them 100%), and the other $15+ million? I guess that the city could do with it whatever they choose. This, my friends, is what I don't see as fair.
So now my head hurts, I know WAY too much about library budgets, and I still don't know where that book is. If only I knew how to hack one of those grossly overdue accounts. I mean, if you owe over $72,000, what's another $50 or so? Oh well, off to dredge the room….
This article is cross-posted from this blog, but since I wrote the post over there, I figure I have the right to steal from myself! My school's English Club goes once a month to a senior community, reads a short story or two, and then leads a short discussion loosely based on what we read. It's really great, and I enjoy it a lot.
For the past week I've been trying to put together a nice, formal write-up of our experiences reading at Chesapeake Place's senior community.
I realized today though, that our times with these lovely people are not formal. Rather, they are an amazing chance to interact with some wonderful people with entertaining life stories and experiences. Our part in the interaction is minimal- all we do is bring a story, read it aloud to them, and ask some interactive questions. Their answers make each meeting priceless.
These people all come from different lives, different backgrounds, and different countries. One woman immigrated from the political unrest in Germany in between the two world wars. Another woman told us what it was like growing up in a large family with a deceased mother and a workaholic father. Yet another woman shared her childhood experiences of living in a Catholic boarding school in Canada.
Our printed, polished, literary short stories by Doyle, O. Henry, and Capote truly pale in comparison to the living, breathing epistles these people share with us. At the same time, it's heartwarming to watch them listen to what we read- the peaceful, thoughtful expressions on their faces, and the way smiles creep onto their faces during humorous parts. They are so appreciative of us coming once a month to spend time with them, but really, I'm grateful to them for their willingness to open up about their lives.
I never leave Chesapeake Place without a feeling of regret- regret that I can't spend more time talking with them, and regret that so many people are missing out on opportunities to interact with people like this. Local senior communities are a wealth of stories and experiences just waiting for an audience- why don't you take an hour or two and invest in these wonderful people? You will never regret it!
I don't have much energy to write tonight- having spent the last 20 hours working on a university project, I'm pretty wiped out. However, one of my resolutions was to not miss a Starbucks Saturday post, and I don't want to slip in January!
I love when we get to do silly things at work. Passion tea, for instance, gives us several opportunities to crack each other up. I heard about some partners this summer who offered to pair the passion tea with the "luscious lemon tart". I don't know who names our pastries, but that name was a doozie and the passion tea suggestion only made it more ridiculous. "Cheery Cherry Pie" was cute and clever though (not to mention delicious!).
Thursday I opened a new bag of passion tea, and had half the bag left over. I folded it over, labeled it properly with "Passion", and then wrote beneath that "we haz it!". That made one of my coworkers crack up, as did writing "I haz a cut" on a leaking jug of milk.
If you don't get those references, then you have to visit this site. Warning: time waster!
On a related note, cleaning up the bottom of an industrial fridge after three cracked jugs of milk have dripped all day and half the night is not fun. Nor is dealing with frozen milk- it doesn't foam well. I tried explaining this to the man whose cappuccino I had to make over (not enough foam in it), but I don't think he believed me. I'm not a bad drink maker, it's just the product giving us a hard time.
Our Christmas party is this weekend though, and I think that we're going to have a ton of fun outside of the store. I can't wait!
When I'm writing, the number 50 is really important to me. In my stories, if I can make it to page 50, then the chances are good that I'll be able to finish it off. If I can write 50 words in a post or paper without struggling, then I know I have a good topic.
This is my 50th blog post. It's only been four months, so I feel good about the future of this place. Fifty posts, and I'm still having fun!
In honor of the milestone, here are 50 random facts from this website. The comments in italics are mine. Enjoy!
2. If you stop getting thirsty, you need to drink more water. For when a human body is dehydrated, its thirst mechanism shuts off.
4. Your tongue is germ free only if it is pink. If it is white there is a thin film of bacteria on it.
5. The Mercedes-Benz motto is "Das Beste oder Nichts" meaning "the best or nothing".
7. The pupil of the eye expands as much as 45 percent when a person looks at something pleasing.
8. The average person who stops smoking requires one hour less sleep a night.
10. The roar that we hear when we place a seashell next to our ear is not the ocean, but rather the sound of blood surging through the veins in the ear.
11. Dalmatians are born without spots.
12. Bats always turn left when exiting a cave.
13. The 'v' in the name of a court case does not stand for 'versus', but for 'and' (in civil proceedings) or 'against' (in criminal proceedings).
14. Men's shirts have the buttons on the right, but women's shirts have the buttons on the left.
15. The owl is the only bird to drop its upper eyelid to wink. All other birds raise their lower eyelids.
17. Roosters cannot crow if they cannot extend their necks.
19. Every time you sneeze some of your brain cells die.
20. Your left lung is smaller than your right lung to make room for your heart.
21. The verb "cleave" is the only English word with two synonyms which are antonyms of each other: adhere and separate.
23. When hippos are upset, their sweat turns red.
24. The first Harley Davidson motorcycle was built in 1903, and used a tomato can for a carburetor.
25. The lion that roars in the MGM logo is named Volney.
26. Google is actually the common name for a number with a million zeros.
29. The attachment of the human skin to muscles is what causes dimples.
30. There are 1,792 steps to the top of the Eiffel Tower.
31. The sound you hear when you crack your knuckles is actually the sound of nitrogen gas bubbles bursting.
32. Human hair and fingernails continue to grow after death.
33. It takes about 20 seconds for a red blood cell to circle the whole body.
34. The plastic things on the end of shoelaces are called aglets.
35. Most soccer players run 7 miles in a game.
37. Every day 400,000 babies are born, and 140,000 people die.
40. The only 2 animals that can see behind itself without turning its head are the rabbit and the parrot.
43. Do you know the names of the three wise monkeys? They are:Mizaru(See no evil), Mikazaru(Hear no evil), and Mazaru(Speak no evil).
44. Women blink nearly twice as much as men.
46. Large kangaroos cover more than 30 feet with each jump.
50. The human heart creates enough pressure while pumping to squirt blood 30 feet!!
Work today was rough. I heard a lot of sad stories, and saw a lot of pain and confusion in people's faces. From the parent that has to tell his daughter that months of chemo didn't work, to the mother who realizes that her last child is growing up too fast while her oldest is drifting off, there's a lot of pain in people's lives.
This song is running through my head on a continual loop- every story I heard, every flash of pain I saw brought a different part of the lyrics to mind. Feel free to listen, feel free to read the lyrics.
But above all, dear customers, remember that this little barista cares about you and is praying for you. I may not be able to do more than offer you coffee and a listening ear, but I'm there for you whenever. Be at peace.
Lately I've been wondering exactly where the fine line between helping people and hindering them in their personal growth is. I get frustrated when people are supposed to do something, and then they don't. So, do I continue to poke, prod, and remind them about their commitments? Or do I just grit my teeth and complete the project myself just so it gets done?
Both tactics have their pros and cons. To continually be reminding people is stressful for me, and annoys them. On the other hand, this does give them the opportunity to step up and complete the project. I may have a heart attack, but at least they get the satisfaction of a job well done.
To do the project myself also stresses me out, but the job is done to my liking. The only bad thing is that the person with the "responsibility" doesn't have to follow through with their commitment. While this might help them out in the short term, it doesn't teach them to manage their time and responsibilities.
Both plans stress me out, and we all know that I can't stand any more stress then I already have. I'm not sure if there is an alternative that doesn't cause stress. If there is one out there, I'd love to know what it is.
Tonight, I chose the latter plan of attack. I must admit that I found myself growing very annoyed to have to do this on top of all the other work I have this week, but in the end it felt good. The project is done, I'm set up better for the next time I have to do it, and I can sleep well tonight knowing that all is well.
Still, it doesn't seem very fair. Welcome to the real world, I guess!
On Tuesday, Starbucks rolled out a bunch of new teas and new healthy food. This was my first time working a rollout day, and I noticed some interesting things.
We do sometimes get send foods in advance to test out so we can tell our customers about them. However, we are not sent everything. Sometimes, we don't even get the food for the customers to buy on rollout day. Here we are with this huge poster of our new sandwiches, and the warehouse forgot to bring us our order. Really, they did. It was a little embarrassing to tell customers "no, we don't have the new food. No, it didn't sell out by 8 am, we never got in the shipment. No, there was nothing we could do to prevent this from happening." The day was sporting in that respect!
Here's a good one- did you know that the new tea sachets are made of nylon? Neither did I, but when a customer asked the question of us, I spent 20 minutes on the phone with Tazo tracking down the answer. The Tazo people are really nice though, so if you ever have tea questions don't hesitate to call the number on the back of your box.
Rooibos is the most difficult tea name for customers to pronounce. We get "roo-i-bos", "roo-bos", "roo-boss", and a plethora of other variations. I don't blame them- it's a confusing little word. For what it's worth, the proper pronunciation is "roy-bus". Yup, roy-bus. I told you I don't blame people who can't get it on their own!
Lucy's cookies, though in Starbucks across the nation, are from right here in Hampton Roads. Check out the Virginian-Pilot article here. I love cool stories like this- and yes, the cookies are super yummy! We can be proud to call this a local company.
I, personally, am addicted to the glazed cashews with pomegranate and vanilla- and I don't even like cashews that much. They are just the right blend of sweet and salty, with a little bit of sticky thrown in. By the end of the first day I got a few customers as hooked on them as I am!
The new rewards program is still confusing, but 13 more stars and I'm at the gold level. For what it's worth, the little cup with the stars on "your Starbucks account" is as addictive to click on as that Poke the Penguin game. The stars just keep jumping around, but they are so cute! I also just got a coupon for a free oatmeal, which will be nice during my morning shift next week.
I know this is a bit of a random post today but it was a random Starbucks week, so it all works out in the end. Have a good week, and happy coffee and tea drinking!
I have an active interesting in archaeology. If you don't believe me, then just looking at the archaeology books on my shelf, the National Geographic and Archaeology Today magazines scattered around my room, and the dirt on my hands. Okay, I'm kidding about the last one, but the other two are true. There's just something about digging into the past that fascinates me.
Last spring I took a Biblical Archaeology class at university, and tonight I pulled out my books to reference them for another class. Specifically, I've been studying whether archaeology disproves the Bible, or if it confirms the Bible's veracity. One of the most interesting books I've read on this subject is titled "What Did the Biblical Writers Know and When Did They Know It? What archaeology can tell us the reality of ancient Israel". Snappy title, I know.
The author is a long-time archaeologist named William Dever. After devoting his whole life to digging up the past, Dever uses this book to present his arguments against deconstructionists who say that the study of history is irrelevant in today's postmodern world. They even go so far as to say that the field of archaeology is pointless and should have been abandoned decades ago.
Put yourself for a moment in Dever's place. Here he is, getting on in years, spending most of his life digging up the past and now some upstart, pseudo-erudite scholars want to tell him that his work is meaningless, pointless, and obsolete. For most of you, dear readers, your contact with archaeology stems mainly from Indiana Jones and Amelia Peabody. Modern archaeology is nothing like the action-packed adventures of these characters. Basically, you spend months findings sponsors to pay for your expenses and crew. Then, you spend a few months in the relentless sun, systematically digging through an endless sandbox with little more than a toothbrush and tweezers, hoping to find something worthwhile. Maybe you will find an old mosaic, or the corner of a house. Mostly though, you will find little but garbage and potsherds, so you will try to pick up any contextual clues you can from these objects in order to gain more support for your next season.
I can't fully wrap my mind around how frustrating it must be.
So, at this point you may be wondering what importance archaeology can have in our lives. Good question! Well, first there's the old saying that those who forget the past are doomed to repeat it. By conducting archaeological excavations, we can learn and understand the history of an area. Sometimes the lessons are cultural- for example finding out that a city turned into a ghost town because the government was overthrown. Other times, archaeologists find clues to the history of the land that will make a difference in how we develop it in modern times. For example, if an excavation finds a civilization buried suddenly in mud, then we can surmise that the area was prone to sudden mudslides, and still may be unstable.
Biblically, archaeology provides some of the most compelling outside evidence that the Bible is real. We read about how the wall of Jericho fell inward by the power of God. Then, we find archaeological evidence of a city called Jericho whose walls fell inward. Given this information, archaeologists can make a correlation between the evidence and the accounts and conclude that the Biblical account is accurate. When we find seals, cartouches, and engravings that speak of people and events we read about in the historical books of the Bible, we can conclude that the events written there are true and accurate. In fact, Dever ultimately claims that archaeology can and does prove the veracity of the Bible. He believes that the details contained in the ancient scrolls and confirmed by archaeological discoveries are much too precise to be made up. Therefore, archaeology confirms the Bible and by doing so confirms the validity of our faith.
Just think- all of that meaning from a clump of dirt and sand!